DUE DILIGENCE IN PHARMACEUTICAL INDUSTRY

Due Diligence in Pharmaceutical Industry

Due diligence in Pharmaceutical Industry is the thorough review and assessment of a potential asset to determine the asset’s viability (unknowns, benefits, and risks). Due diligence involves a detailed review of available data, relevant regulations, and Literature to guide informed licensing decisions and negotiations. As the pharmaceutical industry reaches record numbers of acquisitions in recent years, the challenges of acquiring assets are sure to be present.

Why Choose Knors Pharma Solutions for Regulatory Due Diligence in Pharmaceutical Industry ?

• Help identifying Project Engineering Consultants for the new R&D facility • Support identifying a right partner for your requirements of Formulation Development including parenteral.

• Guidance for Contract Manufacturing and R&D space for Pharmaceuticals • Evaluate process parameters for manufacturing from a compliance perspective.

Regulatory Affairs Due Diligence Knors Pharma approach to regulatory affairs is to match regulatory expertise with scientific, clinical, nonclinical, and overall drug development expertise to support marketing approval and market acceptance.

Knors Pharma team of regulatory affairs professionals understand the statutes, key regulatory opinions, and procedures that make for successful interactions with regulatory authorities like the FDA. However, we also realize that this expertise is not enough. Equally important is the ability to generate well-written and succinct arguments that are grounded in proven scientific, regulatory, and overall drug development principles.

CONTACT US www.knorspharma.com +91- 9878880408, 0162-351544 knorspharma@gmail.com